r-Lung-SARS-CoV-2 model
zPREDICTAA human 3D airway screening platform to identify agents with antiviral activity.
Drug discovery > Basic Research Products & Reviews
25
Products, services, reviews and techniques used in the preliminary investigations of the disease; the cell biology, genetics and protein pathways using tissue culture, cloning and imaging.
Selected Filters:
TurboQ Real-Time PCR System
Blue-Ray BiotechTurboQ Real-Time PCR system is designed for multiplex and routine PCR applications with up to 4 targets. Inheriting the proven PCR instrument core competency from Blue-Ray Biotech, TurboQ brings versatile features to help bio-scientists in performing diagnostic testing and researches.
Human NGF knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: 4 bp deletion in exon 3
Human PXN knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 4
Human POLL knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 2 and Insertion of the selection cassette in exon 2
Human LOXL2 knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 4 and Insertion of the selection cassette in exon 4
Human CHEK2 knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 5
Human PDK1 knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 1
Human BAD knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 2
Human EZR knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, 2 bp deletion in exon 6 and Insertion of the selection cassette in exon 6
Human TLE1 knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 12 and 4 bp deletion in exon 12
Human LAMP2 knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 1
Human NBN knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, 16 bp deletion in exon 2 and 1 bp insertion in exon 2
Human ARRB2 knockout HEK293T cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 4
Human HK1 knockout HEK293T cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 10
Human CASP8 knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: 5 bp deletion in exon 3
Human LDHB knockout HEK293T cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 2
Human LMNB1 knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, 2 bp deletion in exon 1 and 2 bp insertion in exon 1
Human MAPK14 knockout HEK293T cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, 11 bp deletion in exon 1 and 1 bp insertion in exon 1
Human MKI67 knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: 7 bp deletion in exon 7
Human MLKL knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 2 bp deletion in exon 2
Human CD9 knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 3
Human HMGB1 knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 2
Human MSH6 knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 4
Human FOXA1 knockout HeLa cell line
Abcam plcKnockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 4 bp insertion in exon 2